Erythroid crisis caused by parvovirus B19 transmitted via red blood cell transfusion

Internal Medicine

Volumn 50, Issue 20, 2011, Pages 2379-2382

  Tsukada, Yuiko ^a   Yokoyama, Kenji ^a   Ishida, Akaru ^b   Handa, Makoto ^a   Mori, Takehiko ^a   Kizaki, Masahiro ^c   Okamoto, Shinichiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Horizontal transmission; Parvovirus B19; Polymerase chain reaction; Red blood cell transfusion

Indexed keywords

CLADRIBINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIGEN; VIRUS DNA;

ADULT; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ERYTHEMA INFECTIOSUM; ERYTHROCYTE APLASIA; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; GENE SEQUENCE; GENETIC VARIABILITY; HAIRY CELL LEUKEMIA; HEMAGGLUTINATION TEST; HEMATOPOIESIS; HUMAN; HUMAN PARVOVIRUS B19; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RETICULOCYTOPENIA; TREATMENT DURATION; VIREMIA; VIRUS TRANSMISSION;

ADULT; ERYTHROCYTE TRANSFUSION; ERYTHROID CELLS; HUMANS; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 80054716842     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5458     Document Type: Article

References (12)

1. Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS. A human parvovirus-like virus inhibits hematopoietic colony formation in vitro. Nature 302: 426-429, 1983.
2. Servant A, Lapersche S, Lallemand F, et al. Genetic diversity within human Erythrovirus: identification of three genotypes. J Virol 76: 9124-9134, 2002.
3. Plentz A, Hahn J, Holler E, Jilg W, Modrow S. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation. J Clin Virol 31: 116-119, 2004.
4. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J. Virol 58: 921-936, 1986.
5. Sato H. Comment on the letter to the editor. Japan J Transfusion Med 42: 299-300, 1996.
6. McOmish F, Yap PL, Jordan A. Hart H, Cohen BJ, Simmonds P. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 31: 323-328, 1993.
7. Brown KE. Human parvoviruses. Science 262: 114-117, 1993.
8. Sato H, Takakura F, Kojima E, Fukuda K, Okochi K, Maeda Y. Screening of blood donors for human parvovirus B19. Lancet 346: 1237-1238, 1995.
9. Cohen BJ, Beard S, Knowles WA, Ekkis JS, Joske D, Goldman JM. Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 37: 947-952, 1997.
10. Heegaard ED, Petersen BL. Parvovirus B19 transmitted by bone marrow. Br J Haematol 111: 659-661, 2000.
11. Kleinman SH, Glynn SA, Lee TH, et al. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood 114: 3677-3683, 2009.
12. Hourfar MK, Mayr-Wohlfart U, Themann A, et al. Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion 51: 129-136, 2011.